Jefferies Reiterates Omega Healthcare Investors Buy, Raises PT To $21
Jefferies reiterated its Omega Healthcare Investors (NYSE: OHI) Buy rating and raised its Omega Healthcare Investors price target from $19 to $21 in a research report published today.







